BioMarin (BMRN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2261746/biomarin-bmrn-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2261746
Apr 24, 2024 - The headline numbers for BioMarin (BMRN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
https://www.zacks.com/stock/news/2261602/biomarin-pharmaceutical-bmrn-tops-q1-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2261602
Apr 24, 2024 - BioMarin (BMRN) delivered earnings and revenue surprises of 18.33% and 0.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
0
Is a Surprise Coming for BioMarin (BMRN) This Earnings Season?
https://www.zacks.com/stock/news/2260399/is-a-surprise-coming-for-biomarin-bmrn-this-earnings-season?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-2260399
Apr 23, 2024 - BioMarin (BMRN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
0